Thomas O Carpenter

25PUBLICATIONS
94CO-AUTHORS
Haematological tumoursMedical physicsInfant and child healthAdolescent healthOptometry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 11, 2026
Real-world outcomes in patients with tumor-induced osteomalacia treated vs not treated with burosumab.

|Aug 10, 2026
Burden of Disease in Pediatric Tumor-Induced Osteomalacia: A Literature Review.

|Apr 04, 2026
Real-world Effectiveness of Burosumab Across Age Groups: X-linked Hypophosphatemia (XLH) Disease Monitoring Program.

Leanne M Ward, Thomas O Carpenter, Hamilton Cassinelli

|Mar 30, 2026
Real-world Impact of Treatment on Growth in Children With X-Linked Hypophosphatemia.

Seiji Fukumoto, Dieter Haffner, Erik A Imel

|Feb 02, 2026
Bone Age Delay in X-linked Hypophosphatemia.

Julio Soto, Rucha Anant Patki, Lauren J Ehrlich

|Nov 18, 2025
The prevalence of ENPP1 deficiency in humans with Ossification of the Posterior Longitudinal Ligament and the preclinical efficacy of ENPP1 enzyme therapy in murine Ossification of the Posterior Longitudinal Ligament.

Shivani Srivastava, Hajime Kato, Simon von Kroge

Pageof 5

Frequent Collaborators

12 joint publications

Erik A Imel

9 joint publications

Suzanne M Jan de Beur

9 joint publications

Leanne Ward

8 joint publications

Pablo Florenzano